Apis Capital Advisors, LLC Iovance Biotherapeutics, Inc. Transaction History
Apis Capital Advisors, LLC
- $154 Million
- Q1 2025
A detailed history of Apis Capital Advisors, LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Apis Capital Advisors, LLC holds 1,277,000 shares of IOVA stock, worth $3.41 Million. This represents 2.77% of its overall portfolio holdings.
Number of Shares
1,277,000
Previous 1,363,000
6.31%
Holding current value
$3.41 Million
Previous $10.1 Million
57.84%
% of portfolio
2.77%
Previous 11.03%
Shares
3 transactions
Others Institutions Holding IOVA
# of Institutions
319Shares Held
247MCall Options Held
1.34MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA27.8MShares$74.2 Million0.0% of portfolio
-
Mhr Fund Management LLC New York, NY24.4MShares$65.2 Million12.15% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$56.7 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY12.7MShares$33.9 Million1.77% of portfolio
-
State Street Corp Boston, MA11MShares$29.5 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $421M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...